ESC 365 - Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: PCSK9 inhibitors from Day 1

ESC Professional Premium Access

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: PCSK9 inhibitors from Day 1

Session: Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients

Topic: Statins

Speaker: Doctor S. Mehta (Hamilton, CA)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Shamir R Mehta

McMaster University, Hamilton (Canada)

9 presentations

1 follower

3 more presentations in this session

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: combination therapy from Day 1

Speaker: Doctor M. Lettino (Monza, IT)

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients: together with anti-inflammatory therapy from Day 1

Speaker: Professor M. Sabatine (Boston, US)

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients - discussion

Access the full session

Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients

Speakers: Doctor S. Mehta, Doctor M. Lettino, Professor M. Sabatine

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources